Radiation Oncology Department, University and Spedali Civili Hospital - Brescia, P.le Spedali Civili 1 -, 25123, Brescia, Italy.
Medical Physics, Spedali Civili Hospital - Brescia, P.le Spedali Civili 1 -, 25123, Brescia, Italy.
Radiat Oncol. 2018 Aug 29;13(1):158. doi: 10.1186/s13014-018-1100-4.
Radiotherapy is one of the standard treatments for cutaneous lymphoma and Total Skin Electrons Beam Irradiation (TSEBI) is generally used to treat diffuse cutaneous lymphoma and some cases of localized disease. Helical IMRT (HI) allows to treat complex target with optimal dose distribution and organ at risk sparing, so helical tomotherapy has been proposed as alternative technique to TSEBI but only one preliminary report has been published.
Three patients treated (from May 2013 to December 2014) with Helical IMRT, with a total dose between 24 and 30 Gy, were retrospectively evaluated. Data about dosimetric features, response and acute toxicity were registered and analyzed. Planned target coverage was compared with daily in vivo measures and dose calculation based on volumetric images used for set up evaluation as well.
The patients had a mean measured surface fraction dose ranging from 1.54 Gy up to 2.0 Gy. A planned target dose ranging from 85 to 120% of prescription doses was obtained. All doses to Organs At Risk were within the required constraints. Particular attention was posed on "whole bone marrow" planned V, V and V values, ranging respectively between 23 and 43%, 20.1 and 38% and 9.8 and 24%. A comparison with the theoretical homologous values obtained with TSEBI has shown much lower values with TSEBI. Even if treatment was given in sequence to the skin of the upper and lower hemi-body, all the patients had anaemia, requiring blood transfusions, leukopenia and thrombocytopenia.
Based on our limited results TSEBI should still be considered the standard method to treat total skin because of its pattern of acute and late toxicities and the dose distribution. In this particular case the better target coverage obtained with HI can be paid in terms of worse toxicity. Helical IMRT can instead be considered optimal in treating large, convex, cutaneous areas where it is difficult to use multiple electrons fields in relation with the clinical results and the limited and reversible toxicities.
放射治疗是皮肤淋巴瘤的标准治疗方法之一,全身电子束照射(TSEBI)通常用于治疗弥漫性皮肤淋巴瘤和一些局部疾病。螺旋调强放疗(HI)可用于治疗复杂的靶区,实现最佳的剂量分布和保护危及器官,因此螺旋断层放疗已被提议作为 TSEBI 的替代技术,但仅发表了一份初步报告。
回顾性评估了 3 名(2013 年 5 月至 2014 年 12 月)接受螺旋调强放疗的患者,总剂量为 24 至 30Gy。记录并分析了剂量学特征、疗效和急性毒性的数据。比较了靶区的计划覆盖率与每日体内测量值,以及用于设置评估的体积图像的剂量计算值。
患者的平均体表剂量为 1.54Gy 至 2.0Gy。获得了计划靶区剂量为处方剂量的 85%至 120%。所有危及器官的剂量均在要求的限制范围内。特别关注“全骨髓”计划 V、V 和 V 值,分别为 23%至 43%、20.1%至 38%和 9.8%至 24%。与 TSEBI 获得的理论同源值进行比较,TSEBI 的值明显较低。尽管治疗是按照上下半身皮肤的顺序进行的,但所有患者均出现贫血,需要输血,白细胞减少和血小板减少。
根据我们有限的结果,TSEBI 仍应被视为治疗全身皮肤的标准方法,因为它具有急性和迟发性毒性以及剂量分布的模式。在这种特殊情况下,HI 获得的更好的靶区覆盖率可能会导致更严重的毒性。螺旋调强放疗可被认为是治疗大面积、凸面皮肤区域的最佳方法,在这种情况下,由于临床疗效和有限且可逆转的毒性,使用多个电子野会变得困难。